Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like U.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics' $200M+ IPO January 14, 2018 <b>AstraZeneca HealthCare Foundation</b> Awards More Than $1.75 Million To 10 Grassroots Innovative Heart Health Programs February 7, 2017 FDA Calls Cara Therapeutics' Kidney Disease Drug a Breakthrough, Stock Soars June 22, 2017
<b>AstraZeneca HealthCare Foundation</b> Awards More Than $1.75 Million To 10 Grassroots Innovative Heart Health Programs February 7, 2017